Aging-linked cells found to help tendon repair

Chinese researchers found that p16INK4a-positive support cells, long associated with aging and cellular stress, can drive tendon regeneration in mice. The June study suggests epigenetic targeting may open a new path for stronger healing after tendon injury.

Why it matters: - Tendon injuries often heal with scar tissue that is weaker and less flexible than normal tendon. - Better tendon repair could lower the risk of repeat injury and improve recovery after surgery. - The study points to a new treatment strategy centered on epigenetic pathways rather than scar-prone healing alone.

What happened: - Researchers led by Prof. Shen Liu at Shanghai Jiao Tong University School of Medicine studied p16INK4a-positive cells in injured tendons. - The work was published online June 11, 2026, in Bone Research. - The team tested Achilles tendon injuries in mice and tracked cell activity over time with single-cell RNA sequencing.

The details: - p16INK4a-positive cells were rare in healthy tendons but increased sharply about seven days after injury. - Removing these cells from injured tissue led to poorer healing, weaker and less mature tendons, disorganized collagen fibers, fewer repair cells and more inflammation. - The cells turned out to be mesenchymal cells, a connective tissue cell type. - These cells produced high levels of collagen and factors linked to new blood vessel growth and nerve growth. - The researchers found high JMJD3 levels and low H3K27me3 levels in the p16INK4a-positive mesenchymal cells inside injured tendon tissue. - JMJD3 removed H3K27me3, an epigenetic mark that suppresses repair genes in normal tendons. - When JMJD3 was removed, overall tissue repair worsened. - In cell culture, doxorubicin was used to create tendon-injury-like p16-positive cells. - Blocking JMJD3 with GSK-J4 raised H3K27me3, reduced collagen production and worsened healing. - Blocking EZH2, the enzyme that creates H3K27me3, lowered H3K27me3 and improved collagen organization, tendon-specific repair markers and the mechanical strength of repaired tendons. - The paper's title was "JMD33-driven epigenetic reprogramming of p16INK4a positive cells promotes tendon regeneration" and the DOI is 10.1038/s41413-026-00537-1.

Between the lines: - The findings challenge the idea that p16INK4a-positive cells are mainly harmful because of their link to aging and senescence. - The study suggests these cells can shift from a stress-related state into a repair state when the right epigenetic switch is activated. - Prof. Xiaonan Liu called the work potentially "a game changer" for tendon repair, but that is an interpretation of the study's importance, not a clinical result.

What's next: - The research points to epigenetic targeting as a promising strategy for future tendon injury treatments. - Additional studies will be needed before the mechanism can be tested in people and turned into therapy. - The broader question is whether similar p16INK4a-positive repair roles exist in other injured tissues.